Oral Fluency and the Response to Antidepressant Therapy in the Elderly With a Unipolar Depressive Episode
NCT03227133 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2017-07-24
Summary
The study focuses on the identification of clinical, physiological and morphological markers that could predict the response to antidepressant in elderly suffering from unipolar depressive disorder.
Conditions
- Unipolar Depression
Interventions
- OTHER
-
Neuropsychological evaluations
Neuropsychological evaluations including oral fluency, performed specifically for the study
- OTHER
-
Psychiatric interview
- OTHER
-
Cardiovascular risk assessment
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Principal Investigators
-
Caroline Masse-Sibille, MD · Centre Hospitalier Universitaire de Besançon
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-23
- Primary Completion
- 2019-06-30
- Completion
- 2019-06-23
Countries
- France
Study Locations
More Related Trials
-
Rhythm and Depression
NCT02857036 ·Status: UNKNOWN ·Phase: NA
-
Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
NCT01962753 ·Status: COMPLETED ·Phase: NA
-
Medication Treatment for Depression in Nursing Home Residents
NCT00076622 ·Status: COMPLETED
-
Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression
NCT00178100 ·Status: COMPLETED ·Phase: PHASE4
-
Inflammatory Markers and Resistant Depression
NCT02847533 ·Status: UNKNOWN ·Phase: NA
-
Electronic Training of Elderly Depression With Cognitive Impairment
NCT05588102 ·Status: COMPLETED ·Phase: NA
-
Validation of EmoDTx as a Digital Endpoint for Mood Monitoring in Adult Patients Suffering From Unipolar Depression
NCT06860165 ·Status: RECRUITING
-
Early Prediction of Fluoxetine Response
NCT01075529 ·Status: COMPLETED ·Phase: PHASE4
-
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
NCT07009223 ·Status: RECRUITING ·Phase: NA
-
DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls
NCT05099341 ·Status: RECRUITING ·Phase: NA
-
Neurophysiological Markers in the Depressive Episode Characterized by Anhedonic Drug Resistance: Evaluation of Motor Skills and P300 Wave
NCT04456868 ·Status: TERMINATED ·Phase: NA
-
Major Depressive Disorder In The Elderly
NCT00093288 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Cognitive Inhibition Disorders in Depressed Older Suicide Attempters
NCT01333215 ·Status: UNKNOWN
-
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
NCT02330679 ·Status: UNKNOWN ·Phase: PHASE4
-
Cognitive Markers of Response to Treatment in Resistant Depression
NCT02774980 ·Status: UNKNOWN
-
Multimodal Identification of Depressive Symptoms in the Elderly
NCT07112118 ·Status: NOT_YET_RECRUITING
-
Dichotic Listening as a Predictor of Medication Response in Depression
NCT00296725 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
NCT02960763 ·Status: COMPLETED ·Phase: PHASE4
-
Mobile Sensing and Support for Depression
NCT02776839 ·Status: COMPLETED ·Phase: NA
-
Study of Morphological and Perfusion Imaging Predictors of Pejorative Outcome in Major Depressive Disorder
NCT02286024 ·Status: COMPLETED
-
Mobile Technologies and Post-stroke Depression
NCT04043052 ·Status: COMPLETED ·Phase: NA
-
Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting
NCT05547711 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of a Website to Improve Depression Literacy in Adoldescents
NCT05300217 ·Status: COMPLETED ·Phase: NA
-
Neurofeedback Training For Older Adults
NCT05936697 ·Status: RECRUITING ·Phase: NA
-
Evolution of Dark Ideas When Introducing or Switching an Antidepressant
NCT03327974 ·Status: TERMINATED ·Phase: NA